Magrath George
SEC CIK 1999390 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IRD | Opus Genetics, Inc. | CEO, Dir | 2.12M | $256.8K | $204.9K | 17 | 2023-11-01 | 2026-09-09 |
Most active insiders at IRD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Foundation Fighting Blindness Retinal Degeneration Fund | Dir, See Remarks | — | $15.99M |
| 2 | Gallagher Cam | Dir | $323.9K | — |
| 3 | Magrath George | CEO, Dir | — | $204.9K |
| 4 | Gagnon Robert E. | CFO | — | $190.8K |
| 5 | YERXA BENJAMIN R | Pres, Dir | — | $61.2K |
| 6 | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | — | $58.2K |
| 7 | SCHACHLE JOSEPH K | COO | — | $57.7K |
| 8 | Zaremba Rabourn Amy | Head of Fin. Quality Assurance | — | $23.3K |
| 9 | Bennett Jean | Dir | — | — |
| 10 | Ainsworth Sean | Dir | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-11 16:09 | 2026-09-09 | IRD | Opus Genetics, Inc. | Magrath George | CEO, Dir | M - OptEx | $1.15 | +392.2K | 2.12M | +23% | +$451.0K |
| D | 2026-09-11 16:09 | 2026-09-09 | IRD | Opus Genetics, Inc. | Magrath George | CEO, Dir | F - Tax | $5.97 | -75.5K | 2.05M | -4% | -$451.0K |
| 2026-07-27 16:07 | 2026-07-23 | IRD | Opus Genetics, Inc. | Magrath George | CEO, Dir | S - Sale | $2.95 | -9,475 | 1.73M | -0.5% | -$27.9K | |
| 2026-04-27 16:27 | 2026-04-23 | IRD | Opus Genetics, Inc. | Magrath George | CEO, Dir | S - Sale | $5.22 | -9,511 | 1.74M | -0.5% | -$49.6K | |
| 2026-03-18 | 2026-03-16 | IRD | Opus Genetics, Inc. | Magrath George | CEO, Dir | S - Sale | $5.21 | -24.4K | 1.75M | -1% | -$127.3K | |
| 2026-01-26 | 2026-01-22 | IRD | Opus Genetics, Inc. | Magrath George | CEO, Dir | A - Grant | $0.00 | +483.6K | 1.78M | +37% | $0 | |
| A | 2025-11-05 | 2025-11-01 | IRD | Opus Genetics, Inc. | Magrath George | CEO, Dir | F - Tax | $2.30 | -30.4K | 1.29M | -2% | -$69.8K |
| 2025-11-04 | 2025-11-01 | IRD | Opus Genetics, Inc. | Magrath George | CEO, Dir | F - Tax | $2.30 | -30.4K | 1.29M | -2% | -$69.8K | |
| D | 2025-03-26 | 2025-03-24 | IRD | Opus Genetics, Inc. | Magrath George | CEO, Dir | A - Grant | — | +392.2K | 1.32M | +42% | — |
| D | 2025-03-17 | 2025-03-13 | IRD | Opus Genetics, Inc. | Magrath George | CEO | A - Grant | $0.00 | +330.7K | 929.8K | +55% | $0 |
| 2024-12-30 | 2024-12-26 | IRD | Opus Genetics, Inc. | Magrath George | CEO | P - Purchase | $0.98 | +100.0K | 599.1K | +20% | +$98.0K | |
| 2024-12-23 | 2024-12-23 | IRD | Opus Genetics, Inc. | Magrath George | CEO | A - Grant | $0.00 | +6,200 | 499.1K | +1% | $0 | |
| M | 2024-11-19 | 2024-11-15+ | IRD | Opus Genetics, Inc. | Magrath George | CEO | P - Purchase | $1.01 | +100.0K | 492.9K | +25% | +$101.1K |
| 2024-11-05 | 2024-11-01 | IRD | Opus Genetics, Inc. | Magrath George | CEO | F - Tax | $1.18 | -37.0K | 392.9K | -9% | -$43.7K | |
| 2024-05-21 | 2024-05-17 | IRD | Opus Genetics, Inc. | Magrath George | CEO | P - Purchase | $1.75 | +5,000 | 430.0K | +1% | +$8,750 | |
| 2024-03-20 | 2024-03-18 | IRD | Opus Genetics, Inc. | Magrath George | CEO | P - Purchase | $1.96 | +25.0K | 425.0K | +6% | +$49.0K | |
| D | 2023-11-03 | 2023-11-01 | IRD | Opus Genetics, Inc. | Magrath George | CEO | A - Grant | $0.00 | +400.0K | 400.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations